you are here: Home News Astrazeneca

Astrazeneca

AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
Astra says potential blockbuster reduced high blood pressure
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y
AstraZeneca Pharma, Themis Medicare, PG Electroplast, Shilpa Medicare in Focus | Stocks On Radar
AstraZeneca Pharma shares slip 4% as investors rush to book profits
AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y
AstraZeneca to invest Rs 250 crore for GCC expansion in Chennai
AstraZeneca Standalone March 2024 Net Sales at Rs 383.20 crore, up 34.6% Y-o-Y
Thrombosis with Thrombocytopenia Syndrome: What is TTS, rare side effect of AstraZeneca Covid vaccine?
AstraZeneca acknowledges rare blood clot risk of Covid vaccine in court for first time
AstraZeneca Standalone December 2023 Net Sales at Rs 305.79 crore, up 22.41% Y-o-Y
Pharma stocks rally up to 8% to 52-week highs amid rise in fresh Covid cases
AstraZeneca to exit the manufacturing site in Bangalore 'in due course'
AstraZeneca Pharma fall 3% despite healthy Q2 net profit, revenue growth
AstraZeneca Standalone September 2023 Net Sales at Rs 311.07 crore, up 31.74% Y-o-Y
AstraZeneca Standalone June 2023 Net Sales at Rs 295.47 crore, up 27.17% Y-o-Y
Gainers & Losers: 10 stocks that moved the most on June 2
AstraZeneca gets CDSCO nod for cancer drug
AstraZeneca’s lung cancer drug also approved to treat biliary tract cancer
AstraZeneca Standalone December 2022 Net Sales at Rs 249.81 crore, up 24.58% Y-o-Y
AstraZeneca India gets approval to market anti-diabetes drug
AstraZeneca Standalone September 2022 Net Sales at Rs 236.13 crore, up 19.43% Y-o-Y
AstraZeneca looks to more than double new cancer drugs by 2030

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Astrazeneca

AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y

Astra says potential blockbuster reduced high blood pressure

AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y

AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y

AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y

AstraZeneca Pharma, Themis Medicare, PG Electroplast, Shilpa Medicare in Focus | Stocks On Radar

AstraZeneca Pharma shares slip 4% as investors rush to book profits

AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y

AstraZeneca to invest Rs 250 crore for GCC expansion in Chennai

AstraZeneca Standalone March 2024 Net Sales at Rs 383.20 crore, up 34.6% Y-o-Y

Thrombosis with Thrombocytopenia Syndrome: What is TTS, rare side effect of AstraZeneca Covid vaccine?

AstraZeneca acknowledges rare blood clot risk of Covid vaccine in court for first time

AstraZeneca Standalone December 2023 Net Sales at Rs 305.79 crore, up 22.41% Y-o-Y

Pharma stocks rally up to 8% to 52-week highs amid rise in fresh Covid cases

AstraZeneca to exit the manufacturing site in Bangalore 'in due course'

AstraZeneca Pharma fall 3% despite healthy Q2 net profit, revenue growth

AstraZeneca Standalone September 2023 Net Sales at Rs 311.07 crore, up 31.74% Y-o-Y

AstraZeneca Standalone June 2023 Net Sales at Rs 295.47 crore, up 27.17% Y-o-Y

Gainers & Losers: 10 stocks that moved the most on June 2

AstraZeneca gets CDSCO nod for cancer drug

AstraZeneca’s lung cancer drug also approved to treat biliary tract cancer

AstraZeneca Standalone December 2022 Net Sales at Rs 249.81 crore, up 24.58% Y-o-Y

AstraZeneca India gets approval to market anti-diabetes drug

AstraZeneca Standalone September 2022 Net Sales at Rs 236.13 crore, up 19.43% Y-o-Y

AstraZeneca looks to more than double new cancer drugs by 2030